Labcorp (LH) Misses Q2 EPS by 29c, offers guidance

Labcorp (NYSE: LH) reported Q2 EPS of $3.42, $0.29 worse than the analyst estimate of $3.71. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $3.76 billion.
Guidance:
Full-Year 2023 Guidance from Continuing Operations: Adjusted EPS of $13.00 to $14.00 and Free Cash Flow of $0.8 billion to $1.0 billion

For earnings history and earnings-related data on Labcorp (LH) click here.

You May Also Be Interested In

• Labcorp acquires MLM Medical Labs to expand lab network
• JPMorgan Upgrades Lithium Americas Corp. (LAC:CN) (LAC) to Overweight
• Casey's General Stores (CASY) Tops Q1 EPS by 69c